Terms: = Liver cancer AND PPP6C, O00743, 5537, ENSG00000119414
5 results:
1. Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: systematic review and meta-analysis.
Liu J; Tian Y; Fu X; Mu C; Yao M; Ni Y; Liu Y; Li Z
Chin Med J (Engl); 2022 Jul; 135(14):1682-1691. PubMed ID: 36070463
[TBL] [Abstract] [Full Text] [Related]
2. The cancer driver genes IDH1/2, JARID1C/ KDM5C, and UTX/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism.
Chang S; Yim S; Park H
Exp Mol Med; 2019 Jun; 51(6):1-17. PubMed ID: 31221981
[TBL] [Abstract] [Full Text] [Related]
3. Multifunctional Effects of a Small-Molecule STAT3 Inhibitor on NASH and Hepatocellular Carcinoma in Mice.
Jung KH; Yoo W; Stevenson HL; Deshpande D; Shen H; Gagea M; Yoo SY; Wang J; Eckols TK; Bharadwaj U; Tweardy DJ; Beretta L
Clin Cancer Res; 2017 Sep; 23(18):5537-5546. PubMed ID: 28533225
[No Abstract] [Full Text] [Related]
4. MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma.
Wu N; Liu X; Xu X; Fan X; Liu M; Li X; Zhong Q; Tang H
FEBS J; 2011 Jun; 278(12):2044-54. PubMed ID: 21481188
[TBL] [Abstract] [Full Text] [Related]
5. Characteristics and course of small hepatocellular carcinomas in patients with hepatitis C virus types 1 and 2.
Toyoda H; Kumada T; Nakano S; Takeda I; Sugiyama K; Kiriyama S; Sone Y; Hisanaga Y
J Med Virol; 2001 Feb; 63(2):120-7. PubMed ID: 11170048
[TBL] [Abstract] [Full Text] [Related]
